Beyond the Biospecimen

Welcome to Sanguine’s LinkedIn Newsletter - Beyond the Biospecimen. In this newsletter we highlight a few topics each month about biospecimens for research and the data associated with the sample.

New Year, New Look, and New Conditions?

Happy 2025! In this edition of Beyond the Biospecimen, we focus on what is new including our offerings, our website, and conditions that we think will make finding the biospecimens you need faster and easier.

Our Offerings

ICYMI - we now offer LeukoCert? GMP-grade healthy leukopaks. LeukoCert joins our apheresis family of LeukoCore?, healthy and disease-state RUO leukopaks, and LeukoLot?, cryopreserved PBMCs derived from RUO leukopaks. With our new website, you can now easily request a quote for exactly the type of apheresis product you need. Check out our healthy and 80+ disease-state apheresis products here.

Our Website

Along with the new apheresis product pages described above, we have new inventory pages. These pages allow you to request the plasma, serum, and PBMCs you need. We also have additional sample types in our inventory, just contact us to learn more.?

Check out our new navigation. We think it makes it easier for you to find the services, products, and resources you need to secure the biospecimens essential for your research.

New Conditions

At Sanguine we continue to add new conditions to our portfolio, as well as, grow our Donor Network to accommodate your research needs. Recently we have grown our rare disease community adding amyloidosis, autoimmune hepatitis, Pompe disease, and sarcoidosis. Learn more about all the Rare Conditions within our community here.?

Another new development in our Donor Community is that we have added ankylosing spondylitis and antiphospholipid syndrome (APS). Explore our Donor Community here and never hesitate to contact us about additional conditions.?